Skip to main content
Figure 4 | BMC Medical Genomics

Figure 4

From: An array CGH based genomic instability index (G2I) is predictive of clinical outcome in breast cancer and reveals a subset of tumors without lymph node involvement but with poor prognosis

Figure 4

Prognostic value of the G2I on independent data set. (A) Scatter plot of 168 breast cancers from which BAC array CGH data were available [21] according to the two items and the previously defined thresholds of the G2I. M+: metastatic relapse; M-: absence of local or metastatic relapses after five years of follow-up. (B): Kaplan Meier curves showing metastasis-free survival at 10 years for the three G2I classes. Green: G2I-1, blue: G2I-2, red: G2I3; the number of tumors in each G2I class is given in parenthesis. HR: hazard ratio (log-rank test).

Back to article page

BMC Medical Genomics

ISSN: 1755-8794

Contact us